Bridgewater Just Sold Salesforce: A Patient-Stock Debate
Bridgewater Associates exits its Salesforce stake, prompting a broader discussion on how patient capital should value...
Who Should Use Target Date Funds Vs Index Funds
This guide clarifies which investors benefit most from target date funds versus index funds, focusing on goals and involvement level.
26,623 articles
Elon Musk Grok Predicts Global Gold Rally Through 2026
Gold investors are watching Grok AI forecasts as prices hover near current levels while a structural bull case builds...
Synopsys Eyes Upside Despite Pullback, Analysts Say
Synopsys stock stabilizes after a pullback, with analysts signaling meaningful upside driven by AI-enabled chip desig...
Start with an Exposure Audit for Your Real Estate Listing
Stalled listings in mid-2026 are being tackled with a practical exposure audit that prioritizes visibility and buyer ...
Despite Tariff Ruling, This Coffee Maker Bets on Survival
A Supreme Court ruling nullifies broad tariffs, but a mid-sized U.S. coffee roaster warns refunds are unlikely and co...
This Much Berkshire Hathaway: Coca-Cola and AMEX Dividends 2025
Berkshire Hathaway’s long-running bets on Coca-Cola and American Express continue to pay off in 2025. This article br...
Economic Growth Bounces Back as AI Buildout Fuels Q1 Gains
The U.S. economy grew at a 2.0% annualized rate in Q1, powered by AI-related investment and resilient consumer spendi...
Forget Cerebras Systems’ Focus: Invest in Alibaba Now
Cerebras Systems’ IPO surge has cooled, steering investors toward Alibaba as a more scalable AI platform. This report...
Memory Melt-Up Lifts SanDisk and WD as Micron Rally
A broad rally in memory stocks follows a strong Micron session, lifting SanDisk and Western Digital as AI datacenter ...
Tech Stocks Lead Market as Fed Rate Hike Fears Resurface
Tech stocks lead market declines as traders weigh higher-for-longer rates against cooling AI chip enthusiasm and a su...
Who Is the World’s Second Richest Person Right Now?
The world’s second richest person title is a moving target as stock prices swing. Here's who holds it this week and w...
Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status